SMAD SIGNALING IN ANGIOTENSIN II-MEDIATED RENAL FIBROSIS

血管紧张素 II 介导的肾纤维化中的 SMAD 信号传导

基本信息

  • 批准号:
    7061191
  • 负责人:
  • 金额:
    $ 32.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-05-01 至 2009-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Ang II plays a pivotal role in the development of end-stage renal disease. It is known that Ang II acts by stimulating TGF-b to mediate renal fibrosis. However, our preliminary studies showed an additional signaling pathway that may be required for renal fibrosis induced by Ang II. We found that Ang II is able to activate the TGF-b signaling pathway, Smad2 and SmadS. This response leads to increased collagen production by two mechanisms: 1) an acute pathway (5-30 minutes) via activation of the ERK/p38 MAP kinases; and 2) a late mechanism (24 hours) that acts through autocrine TGF-b and leads to fibrosis. Furthermore, we also find that mice null for SmadS are protected against renal fibrosis, while mice that are conditionally deleted for Smad2 enhance SmadS signaling and renal fibrosis in response to Ang II. Thus, we hypothesize that Smad signaling is a key to the development of renal fibrosis in response to Ang II. We plan to test this hypothesis and to determine the new role for the Ang Il-Smad signaling pathway in renal fibrosis by pursuing three specific aims. In Aim 1, we will study that Ang II activates Smads via an acute (5-30 mins) ERK/p38 MAPKdependent and a late (20 hrs) classic TGF-b-dependent pathways. In Aim 2, we will dissect the functional role of TGF-b-dependent and independent Smad signaling pathways in Ang ll-induced renal fibrosis in mesangial cells (MC) and tubular epithelial cells (TEC) that do or do not express TGF-b or TbRII, and in conditional TbRII KO mice. In Aim 3, we will dissect the specific role of Smad2 or SmadS in Ang ll-mediated renal fibrosis. This will be examined in mouse embryonic fibroblasts, MC, and TEC that do or do not express Smad2 and SmadS and in SmadS KO and conditional Smad2 KO mice. We expect that the outcomes obtained from this study will support the central hypothesis and provide new insights into the pathogenesis of Ang ll-mediated renal fibrosis and valuable information for the development of new therapeutic strategies to combat renal fibrosis by targeting Smad signaling.
描述(由申请人提供):血管紧张素II在终末期肾病的发展中起着关键作用。已知Ang II通过刺激TGF-β介导肾纤维化而起作用。然而,我们的初步研究表明,一个额外的信号通路,可能需要为肾纤维化的血管紧张素II诱导。我们发现Ang II能够激活TGF-β信号通路Smad 2和SmadS。这种反应通过两种机制导致胶原蛋白产生增加:1)通过ERK/p38 MAP激酶活化的急性途径(5-30分钟);和2)通过自分泌TGF-β起作用并导致纤维化的晚期机制(24小时)。此外,我们还发现SmadS缺失的小鼠受到保护免受肾纤维化,而Smad 2条件性缺失的小鼠增强SmadS信号传导和肾纤维化对Ang II的响应。因此,我们推测Smad信号是血管紧张素II引起肾纤维化的关键。我们计划通过以下三个具体目标来验证这一假设,并确定血管紧张素Ⅱ-Smad信号通路在肾纤维化中的新作用。目的1:研究Ang Ⅱ通过急性(5-30 min)ERK/p38 MAPK依赖性途径和晚期(20 h)经典TGF-β依赖性途径激活Smads。在目标2中,我们将剖析TGF-β依赖性和非依赖性Smad信号通路在表达或不表达TGF-β或TbRII的系膜细胞(MC)和肾小管上皮细胞(TEC)中以及在条件性TbRII KO小鼠中Ang II诱导的肾纤维化中的功能作用。在目的3中,我们将剖析Smad 2或SmadS在Ang II介导的肾纤维化中的具体作用。这将在表达或不表达Smad 2和SmadS的小鼠胚胎成纤维细胞、MC和TEC以及SmadS KO和条件性Smad 2 KO小鼠中进行检查。我们期望从该研究获得的结果将支持中心假设,并提供对Ang II介导的肾纤维化的发病机制的新见解和用于开发通过靶向Smad信号传导来对抗肾纤维化的新治疗策略的有价值的信息。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WILLIAM Evans MITCH其他文献

WILLIAM Evans MITCH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WILLIAM Evans MITCH', 18)}}的其他基金

Protein Nutrition in Experimental Uremia
实验性尿毒症中的蛋白质营养
  • 批准号:
    8004337
  • 财政年份:
    2010
  • 资助金额:
    $ 32.7万
  • 项目类别:
Renal Inflammation: Mechanisms and Consequences
肾脏炎症:机制和后果
  • 批准号:
    7508950
  • 财政年份:
    2007
  • 资助金额:
    $ 32.7万
  • 项目类别:
Renal Inflammation: Mechanisms and Consequences
肾脏炎症:机制和后果
  • 批准号:
    7500570
  • 财政年份:
    2007
  • 资助金额:
    $ 32.7万
  • 项目类别:
Renal Inflammation: Mechanisms and Consequences
肾脏炎症:机制和后果
  • 批准号:
    7500557
  • 财政年份:
    2007
  • 资助金额:
    $ 32.7万
  • 项目类别:
Renal Inflammation: Mechanisms and Consequences
肾脏炎症:机制和后果
  • 批准号:
    7059451
  • 财政年份:
    2003
  • 资助金额:
    $ 32.7万
  • 项目类别:
Renal Inflammation: Mechanisms and Consequences
肾脏炎症:机制和后果
  • 批准号:
    7230971
  • 财政年份:
    2003
  • 资助金额:
    $ 32.7万
  • 项目类别:
Research Training in Renal Diseases
肾脏疾病研究培训
  • 批准号:
    7901050
  • 财政年份:
    2003
  • 资助金额:
    $ 32.7万
  • 项目类别:
Research Training in Renal Diseases
肾脏疾病研究培训
  • 批准号:
    8513313
  • 财政年份:
    2003
  • 资助金额:
    $ 32.7万
  • 项目类别:
Renal Inflammation: Mechanisms and Consequences
肾脏炎症:机制和后果
  • 批准号:
    6883939
  • 财政年份:
    2003
  • 资助金额:
    $ 32.7万
  • 项目类别:
Research Training in Renal Diseases
肾脏疾病研究培训
  • 批准号:
    8102182
  • 财政年份:
    2003
  • 资助金额:
    $ 32.7万
  • 项目类别:

相似海外基金

Decline of tissue stem cell proliferation and differentiation ability by chronic renal failure and preventive effects by omega-3 polyunsaturated fatty acid
慢性肾功能衰竭引起的组织干细胞增殖和分化能力下降及omega-3多不饱和脂肪酸的预防作用
  • 批准号:
    22K05529
  • 财政年份:
    2022
  • 资助金额:
    $ 32.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanism of hyperhomocysteinemia in chronic renal failure and its involvement in the development of cardiovascular disease
高同型半胱氨酸血症导致慢性肾功能衰竭的机制及其与心血管疾病发生发展的关系
  • 批准号:
    20K07188
  • 财政年份:
    2020
  • 资助金额:
    $ 32.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Renal function and chronic renal failure mechanisms based on biomechanical modeling
基于生物力学模型的肾功能和慢性肾衰竭机制
  • 批准号:
    20K04281
  • 财政年份:
    2020
  • 资助金额:
    $ 32.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms of decline of cognitive functions by chronic renal failure involving neurogenesis
慢性肾衰竭涉及神经发生的认知功能下降机制
  • 批准号:
    17K01865
  • 财政年份:
    2017
  • 资助金额:
    $ 32.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of intestinal microbiota and barrier function in chronic renal failure and therapeutic strategy
慢性肾功能衰竭肠道菌群及屏障功能分析及治疗策略
  • 批准号:
    17K09722
  • 财政年份:
    2017
  • 资助金额:
    $ 32.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clinical administration of AIM and establishment of renal function markers in cats with spontaneous chronic renal failure
自发性慢性肾功能衰竭猫的 AIM 临床应用及肾功能标志物的建立
  • 批准号:
    17K08097
  • 财政年份:
    2017
  • 资助金额:
    $ 32.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Studies on the pathological mechanisms of feline morbillivirus associated with chronic renal failure
猫麻疹病毒与慢性肾功能衰竭相关病理机制的研究
  • 批准号:
    16K15039
  • 财政年份:
    2016
  • 资助金额:
    $ 32.7万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
The role of Ca channels and KV1.3 channels in chronic renal failure and the development of preventive therapy against septic acute renal failure progressing to chronic hemodialysis
Ca通道和KV1.3通道在慢性肾功能衰竭中的作用以及脓毒症急性肾功能衰竭进展为慢性血液透析的预防治疗的发展
  • 批准号:
    16K20079
  • 财政年份:
    2016
  • 资助金额:
    $ 32.7万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Molecular mechanism elucidation of iron metabolism abnormality and sarcopenia onset in chronic renal failure
慢性肾功能衰竭铁代谢异常和肌少症发病的分子机制阐明
  • 批准号:
    16K16603
  • 财政年份:
    2016
  • 资助金额:
    $ 32.7万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Establishment of a new treatment strategy targeting inflammation for patients with chronic renal failure
建立针对慢性肾功能衰竭患者炎症的新治疗策略
  • 批准号:
    15K09289
  • 财政年份:
    2015
  • 资助金额:
    $ 32.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了